Krishna Institute of Medical Sciences Reports Mixed Financial Results for Q1 FY25

Krishna Institute of Medical Sciences, a midcap healthcare services company, has recently announced its financial results for the quarter ended June 2024. The company has seen a negative financial performance with a score of -11, which has improved from -24 in the last three months.

Despite this, there are some positive aspects to the company’s financials. The net sales for the quarter were the highest in the last five quarters at Rs 688.40 crore, indicating a positive trend in the near term. The operating profit (PBDIT) for the quarter was also the highest in the last five quarters at Rs 179.40 crore, with a positive trend in the near term.

However, there are some areas of concern for Krishna Institute of Medical Sciences. The interest cost for the half-yearly period has grown by 60.73% compared to the previous half-yearly period, indicating increased borrowings. The debt-equity ratio is also at its highest in the last five half-yearly periods, with a continuous increase each half-year. This suggests that the company is relying more on borrowings to fund its operations, which may lead to a stressed liquidity situation.

Additionally, the debtors turnover ratio for the half-yearly period is at its lowest in the last five periods, indicating a slower pace in settling debts. The company’s non-operating income for the quarter was the highest in the last five quarters, but this may not be sustainable as it comes from non-business activities.

Overall, while Krishna Institute of Medical Sciences has shown some positive trends in its financials, there are also some areas of concern that investors should keep in mind. MarketsMOJO has given a ‘Hold’ call for the company’s stock, suggesting a neutral stance for investors.